Clincosm LogoSign in Get a demo

Increasing Breast Cancer Screening in Chinese Immigrants

Sponsor
Icahn School of Medicine at Mount Sinai (Other)
Overall Status
Recruiting
CT.gov ID
NCT05089292
Collaborator
National Cancer Institute (NCI) (NIH)
156
Enrollment
1
Location
1
Arm
23
Anticipated Duration (Months)
6.8
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The long-term goal of this research is to increase breast cancer screening rates in NYC Chinese immigrants. The researchers plan to accomplish this objective by developing and testing a culturally- and linguistically-adapted Witness Project program for Chinese immigrants. To inform the intervention development, the study team will identify barriers and facilitators to breast cancer screening in Chinese immigrants through individual qualitative interviews.

A total of 156 participants will be recruited during the entire study.

In Aim 1 which started in July 2021, 60 women were recruited for in-depth interviews to assess their breast cancer knowledge, perceived barriers and benefits/risks to completing mammography, perceived susceptibility to breast cancer, fatalism, screening intention, acculturation, language preference, and health literacy.

In Aim 2, 96 women will be recruited to participate in the pilot testing of the intervention. Recruitment will take place at community sites that serve Chinese immigrants in New York City. Enrollment for Aim 2 is anticipated to start in March of 2022.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Narrative breast health education
 N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
156 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Pre/Post-test designPre/Post-test design
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
Increasing Breast Cancer Screening in Chinese Immigrants
Actual Study Start Date :
Jul 1, 2021
Anticipated Primary Completion Date :
Jun 1, 2023
Anticipated Study Completion Date :
Jun 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Chinese Immigrants

NYC Chinese immigrants provided with narrative breast health education

Behavioral: Narrative breast health education
Health education program utilizing narrative messages to promote breast cancer screening in Chinese immigrant women will be delivered in a group format in the community

Outcome Measures

Primary Outcome Measures

  1. Screening mammogram completion [6 months post intervention]

    Self-report completion of screening mammogram (Yes/No)

Secondary Outcome Measures

  1. Screening mammogram intention [6 months post intervention]

    Question: How likely are you to undergo a screening mammogram in the next 6 months? (Very likely, Somewhat likely, Not sure, Somewhat not likely, Not at all likely)

  2. Change in Feasibility and Acceptability Questionnaire [Baseline and 6 months post intervention]

    Pre- and post-program survey to access feasibility and acceptability of adapted narrative education program. Full scale from 5 - 25, with a higher score indicating greater acceptability.

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

  • ≥ 40 years of age

  • female

  • born in China

  • read and speak Cantonese, Mandarin, or English

Exclusion Criteria:
  • none

Contacts and Locations

Locations

Site City State Country Postal Code
1 Icahn School of Medicine at Mount Sinai New York New York United States 10029

Sponsors and Collaborators

  • Icahn School of Medicine at Mount Sinai
  • National Cancer Institute (NCI)

Investigators

  • Principal Investigator: Lina Jandorf, Icahn School of Medicine at Mount Sinai

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Lina Jandorf, Professor, Director, Icahn School of Medicine at Mount Sinai
ClinicalTrials.gov Identifier:
NCT05089292
Other Study ID Numbers:
  • STUDY-20-01174
  • R21CA249261
First Posted:
Oct 22, 2021
Last Update Posted:
Mar 7, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Lina Jandorf, Professor, Director, Icahn School of Medicine at Mount Sinai
Breast cancer screening
Health education
Chinese immigrant
Health disparities
Additional relevant MeSH terms:
Breast Neoplasms

Study Results

No Results Posted as of Mar 7, 2022